Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-01-24 @ 8:28 PM
Study NCT ID:
NCT06958835
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2025-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Linezolid Plus Standard of Care
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Virulence factors | View |
| None | Linezolid | View |
| None | Bloodstream Infection | View |
| None | Hierarchical composite endpoint | View |
| None | Staphylococcus aureus | View |
| None | Bacteremia | View |
| None | Bacteraemia | View |
| None | Methicillin-resistant Staphylococcus aureus (MRSA) | View |
| None | Penicillin-susceptible Staphylococcus aureus (PSSA) | View |
| None | Methicillin-susceptible Staphylococcus aureus (MSSA) | View |